Dr. Tripathy on the Development of Palbociclib in Breast Cancer

Debu Tripathy, MD, chair of the Department of Breast Medical Oncology at The University of Texas MD Anderson Cancer Center, discusses the development of palbociclib (Ibrance) in breast cancer.

Debu Tripathy, MD, chair of the Department of Breast Medical Oncology at The University of Texas MD Anderson Cancer Center, discusses the development of palbociclib (Ibrance) in breast cancer.

Related Content:

VideosBreast Cancer
CDK4/6 Inhibitors Gain Momentum in Early-Stage Breast Cancer, But More Research is Still Needed
Health Care Professionals Can Fight Burnout Through Their Diet
The Food-Mood Connection: Diet Directly Impacts Emotional Health